Goldman Sachs
CELG

Goldman Sachs’s Celgene Corp CELG Stock Holding History

Goldman Sachs’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-7,449,861
Closed -$740M – 5593
2019
Q3 		$740M Buy
7,449,861
+1,052,450
+16% +$100M 0.21% 79
2019
Q2 		$591M Buy
6,397,411
+358,314
+6% +$34M 0.17% 102
2019
Q1 		$570M Sell
6,039,097
-33,432
-0.6% -$2.92M 0.17% 98
2018
Q4 		$389M Buy
6,072,529
+713,464
+13% +$52.7M 0.12% 139
2018
Q3 		$480M Sell
5,359,065
-1,050,129
-16% -$92.8M 0.12% 151
2018
Q2 		$509M Sell
6,409,194
-3,587,125
-36% -$298M 0.14% 130
2018
Q1 		$892M Buy
9,996,319
+1,757,385
+21% +$169M 0.23% 73
2017
Q4 		$860M Buy
8,238,934
+2,146,831
+35% +$242M 0.21% 69
2017
Q3 		$888M Sell
6,092,103
-59,613
-1% -$8.12M 0.22% 64
2017
Q2 		$799M Buy
6,151,716
+302,937
+5% +$37.1M 0.21% 65
2017
Q1 		$728M Buy
5,848,779
+406,432
+7% +$48.6M 0.2% 78
2016
Q4 		$630M Buy
5,442,347
+1,241,095
+30% +$138M 0.18% 85
2016
Q3 		$439M Sell
4,201,252
-321,476
-7% -$34.8M 0.13% 126
2016
Q2 		$446M Buy
4,522,728
+923,037
+26% +$95.5M 0.15% 107
2016
Q1 		$360M Buy
3,599,691
+349,406
+11% +$36M 0.12% 153
2015
Q4 		$389M Sell
3,250,285
-442,627
-12% -$51.2M 0.12% 157
2015
Q3 		$399M Buy
3,692,912
+229,635
+7% +$28.5M 0.13% 128
2015
Q2 		$401M Sell
3,463,277
-858,556
-20% -$98.2M 0.12% 160
2015
Q1 		$498M Sell
4,321,833
-1,406,048
-25% -$168M 0.16% 115
2014
Q4 		$641M Buy
5,727,881
+357,072
+7% +$37.7M 0.2% 75
2014
Q3 		$509M Sell
5,370,809
-365,565
-6% -$33M 0.16% 105
2014
Q2 		$493M Buy
5,736,374
+1,701,140
+42% +$129M 0.15% 115
2014
Q1 		$282M Sell
4,035,234
-163,374
-4% -$12.9M 0.09% 225
2013
Q4 		$355M Buy
4,198,608
+701,716
+20% +$55.5M 0.12% 169
2013
Q3 		$270M Sell
3,496,892
-170,488
-5% -$11.9M 0.1% 204
2013
Q2 		$215M Buy
+3,667,380
New +$221M 0.08% 244

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Goldman Sachs's CELG Position: Q4 2019 in Review

Goldman Sachs sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 7,449,861 shares — an estimated $740M sold.

Goldman Sachs first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $892M in Q1 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Goldman Sachs reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Goldman Sachs sold 7,449,861 Celgene Corp shares in Q4 2019, an estimated $740M.
  • Goldman Sachs first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Goldman Sachs's Celgene Corp position peaked at $892M in Q1 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Goldman Sachs's 13F filing for Q4 2019, filed 14 Feb 2020.